• Quoth the Raven
    MannKind: My Short Case Remains In Tact $AMRN, $MNKD http://seekingalpha.com/p/1rsbl
    6/10/14
    Reply (6)
    • pollyserial: Wow, that looks like a painful "intact". Good luck with that!
      6/10/14
    • pilot fish: Nothing to see here. As usual, same ole' stuff I'm sure. You've lost any and all street credit. You should contact Taroh card boy...
      6/10/14
    • woodland: $MNKD your short case might remain but I believe the stock is up over 2.00 since you wrote the article , like your writing but this one ??
      6/10/14
    • csymalla: I believe Quoth said the short opportunity is after approval NOT before.
      6/11/14
    • csymalla: There is much denial of possible challenges after approval I can't say I disagree with the short strategy.
      6/11/14
    • woodland: My concern would be that after FDA approval a partnership is announced hence catching the shorts .
      6/11/14